Executive appointments at Ferring

Privately-held Swiss firm Ferring Pharmaceuticals today announced that Paul Navarre has been appointed chief executive of Ferring Holding Inc.

In this role Mr Navarre assumes direct responsibility for all Ferring US activities including commercial operations, clinical development and manufacturing. He succeeds Aaron Graff, who is taking on new responsibilities at Ferring (see below).

Mr Navarre has more than 25 years’ experience in the pharmaceuticals and consumer goods industries. He joins Ferring from Allergan, where as president of Allergan International, he managed a $3 billion specialty care business covering dermatology, ophthalmology, urology and neurosciences. During 10 years at Allergan, Mr Navarre built a strong track record, delivering solid business results and developing multiple successful organizations.